Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 9.50
-0.26 (-2.66%)
At close: Apr 9, 2026
Sinotherapeutics Revenue
In the year 2025, Sinotherapeutics had annual revenue of 446.50M CNY, down -12.73%. Sinotherapeutics had revenue of 115.03M in the quarter ending December 31, 2025, a decrease of -22.80%.
Revenue
446.50M
Revenue Growth
-12.73%
P/S Ratio
9.55
Revenue / Employee
1.43M
Employees
312
Market Cap
4.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 446.50M | -65.12M | -12.73% |
| Dec 31, 2024 | 511.62M | 211.75M | 70.61% |
| Dec 31, 2023 | 299.87M | 52.31M | 21.13% |
| Dec 31, 2022 | 247.56M | -67.91M | -21.53% |
| Dec 31, 2021 | 315.47M | -3.69M | -1.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Yabao Pharmaceutical Group | 2.27B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Huaren Pharmaceutical | 1.26B |
| LanZhou Foci Pharmaceutical | 895.75M |
| Shanghai Xiao Fang Pharmaceutical | 504.59M |